China Gene Therapy Developers Rush To Clinic In 'Winner Takes All' Battle

US IND For First 'Made In China' Contender

Gene therapies for conditions ranging from hemophilia to retinal diseases are blossoming in China and the race in which the winner may take all is on. Driven by ready investors, the field is on the cusp of becoming the latest innovation battleground in the country, while some developers are already moving ahead in the US.

BIOFUTURE FORUM'S GENE THERAPY PANEL HELD IN SHANGHAI JAN 11-12, 2022
BIOFUTURE FORUM'S GENE PANEL DISCUSSION HELD IN SHANGHAI, 11-12 JANUARY 2022 • Source: Brian Yang/Scrip

More from China

More from Focus On Asia